Mild cognitive impairment due to Alzheimer disease in the community

Petersen, Ronald C., Aisen, Paul, Boeve, Bradley F., Geda, Yonas E., Ivnik, Robert J., Knopman, David S., Mielke, Michelle, Pankratz, Vernon S., Roberts, Rosebud, Rocca, Walter A., Weigand, Stephen, Weiner, Michael, Wiste, Heather, Jack, Clifford R.·2013·Annals of Neurology
DOI 10.1002/ana.23931

Cited by (265)

Items 101–200 of 265

  1. Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
    Ricardo Allegri, Patricio Chrem Méndez, Ismael Luis Calandri, Gabriela Cohen, María Martín, María Julieta Russo, Lucía Crivelli, Lucía Pertierra, Fernanda Tapajóz, María Florencia Clarens et al. · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  2. Diagnostic accuracy of the Cogstate Brief Battery for prevalent MCI and prodromal AD (MCI A+T+) in a population‐based sample
    Eva Alden, Shehroo B. Pudumjee, Emily S. Lundt, Sabrina M. Albertson, Mary M. Machulda, Walter K. Kremers, Clifford R. Jack, David S. Knopman, Ronald Carl Petersen, Michelle M. Mielke et al. · 2021 · Alzheimer s & Dementia
  3. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia
    Yujing Zhao, Dana Tudorascu, Oscar L. López, Ann D. Cohen, Chester A. Mathis, Howard Jay Aizenstein, Julie C. Price, Lewis H. Kuller, M. Ilyas Kamboh, Steven Trent DeKosky et al. · 2017 · JAMA Neurology
  4. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer’s disease patients: a retrospective observational study
    Eugenia Scaricamazza, Isabella Colonna, Giulia Maria Sancesario, Francesca Assogna, Maria Donata Orfei, Flaminia Franchini, Giuseppe Sancesario, Nicola Biagio Mercuri, Claudio Liguori · 2019 · Neurological Sciences
  5. Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology
    Laura E.M. Wisse, Robin de Florès, Long Xie, Sandhitsu R. Das, Corey T. McMillan, John Q. Trojanowski, Murray Grossman, Eddie B Lee, David John Irwin, Paul A. Yushkevich et al. · 2021 · Alzheimer s Research & Therapy
  6. A biomarker study in long-lasting amnestic mild cognitive impairment
    Chiara Cerami, Alessandra Dodich, Sandro Iannaccone, Giuseppe Magnani, Roberto Santangelo, Luca Presotto, Alessandra Marcone, Luigi Gianolli, Stefano Francesco Cappa, Daniela Perani · 2018 · Alzheimer s Research & Therapy
  7. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid
    Anna Rosenberg, Alina Solomon, Vesna Jelić, Göran Hagman, Nenad Bogdanović, Miia Kivipelto · 2019 · Alzheimer s Research & Therapy
  8. Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK
    Axel Anders Stefan Laurell, Ashwin V. Venkataraman, Tatjana Schmidt, Marcella Montagnese, Christoph Mueller, Robert J. Stewart, Jonathan R. Lewis, Clare Mundell, Jeremy Darryl Isaacs, Mani Santhana Krishnan et al. · 2024 · The British Journal of Psychiatry
  9. Effect of 12-week home-based cognitive training on cognitive function and brain metabolism in patients with amnestic mild cognitive impairment
    Jinse Park, Si Eun Kim, Eun‐Joo Kim, Byung Inn Lee, Jee Hyang Jeong, Hae Ri Na, Seong Hye Choi, Do‐Young Kang, Kyung Won Park · 2019 · Clinical Interventions in Aging
  10. Altered Whole-Brain Structural Covariance of the Hippocampal Subfields in Subcortical Vascular Mild Cognitive Impairment and Amnestic Mild Cognitive Impairment Patients
    Xuetong Wang, Yang Yu, Weina Zhao, Qiongling Li, Xinwei Li, Shuyu Li, Changhao Yin, Ying Han · 2018 · Frontiers in Neurology
  11. The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects
    the Working Group, Alessandro Iavarone, Michele Carpinelli Mazzi, Gennaro Russo, Francesco D’Anna, Silvio Peluso, Pietro Mazzeo, Vincenzo De Luca, Giuseppe De Michele, Guido Iaccarino et al. · 2018 · Aging Clinical and Experimental Research
  12. Diversity of neurodegenerative pathophysiology in nondemented patients with major depressive disorder: Evidence of cerebral amyloidosis and hippocampal atrophy
    Kuan‐Yi Wu, Kun‐Ju Lin, Chia‐Hsiang Chen, Cheng‐Sheng Chen, Chia‐Yih Liu, Sheng‐Yao Huang, Tzu‐Chen Yen, Ing‐Tsung Hsiao · 2018 · Brain and Behavior
  13. Partnering a Compensatory Application with Activity-Aware Prompting to Improve Use in Individuals with Amnestic Mild Cognitive Impairment: A Randomized Controlled Pilot Clinical Trial
    Maureen Schmitter-Edgecombe, Katelyn Brown, Catherine Luna, Reanne Chilton, Catherine A. Sumida, Lawrence Holder, Diane Cook · 2021 · Journal of Alzheimer s Disease
  14. Harmonization and standardization of biofluid‐based biomarker measurements for AT(N) classification in Alzheimer's disease
    Chiara Giangrande, Vincent Delatour, Ulf Andréasson, Kaj Blennow, Johan Gobom, Henrik Zetterberg · 2023 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  15. Feasibility and acceptance of simultaneous amyloid PET/MRI
    Lisa Schütz, Donald Lobsien, Dominik Fritzsch, Solveig Tiepolt, Peter Werner, Matthias Leopold Schroeter, Jörg Berrouschot, Dorothee Saur, Swen Hesse, Thies H. Jochimsen et al. · 2016 · European Journal of Nuclear Medicine and Molecular Imaging
  16. Tobacco Smoking and Dementia in a Kentucky Cohort: A Competing Risk Analysis
    Erin L. Abner, Peter T. Nelson, Gregory A. Jicha, Gregory E. Cooper, David W. Fardo, Frederick A. Schmitt, Richard J. Kryscio · 2019 · Journal of Alzheimer s Disease
  17. Gray matter changes related to microglial activation in Alzheimer's disease
    Nicolas Nicastro, Maura Malpetti, Elijah Mak, Guy B. Williams, William Richard Bevan-Jones, Stephen F. Carter, Luca Passamonti, Tim D. Fryer, Young T. Hong, Franklin I. Aigbirhio et al. · 2020 · Neurobiology of Aging
  18. Decreased hippocampal metabolism in high‐amyloid mild cognitive impairment
    Bernard Jimmy Hanseeuw, Aaron P. Schultz, Rebecca A. Betensky, Reisa Anne Sperling, Keith A. Johnson · 2016 · Alzheimer s & Dementia
  19. Dual Time-Point [ 18 F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer’s Disease
    Lisa Florek, Solveig Tiepolt, Matthias Leopold Schroeter, Jörg Berrouschot, Dorothee Saur, Swen Hesse, Thies H. Jochimsen, Julia Luthardt, Bernhard Sattler, Marianne Patt et al. · 2018 · Journal of Alzheimer s Disease
  20. Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer's disease: pass or fail?
    Veneziani, Federica, Panza, Francesco, Solfrizzi, Vincenzo, Capozzo, Rosa, Barulli, Maria Rosaria, Leo, Antonio, Lozupone, Madia, Fontana, Andrea, Arcuti, Simona, Copetti, Massimiliano et al. · 2016 · International Psychogeriatrics
  21. The Early Indicators of Functional Decrease in Mild Cognitive Impairment
    Alexandre Kubicki, Lilian Fautrelle, Julien Bourrelier, Olivier Rouaud, France Mourey · 2016 · Frontiers in Aging Neuroscience
  22. Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum
    David S. Knopman, Clifford R. Jack, Emily S. Lundt, Stephen D. Weigand, Prashanthi Vemuri, Val J. Lowe, Kejal Kantarci, Jeffrey L. Gunter, Matthew L. Senjem, Michelle M. Mielke et al. · 2016 · Neurobiology of Aging
  23. Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
    Eleonora Del Prete, Maria Francesca Beatino, Nicole Campese, Linda Giampietri, Gabriele Siciliano, Roberto Ceravolo, Filippo Baldacci · 2020 · Journal of Personalized Medicine
  24. Enhancing prospective memory in mild cognitive impairment: The role of enactment
    Antonina Pereira, Alexandre de Mendonça, Dina Silva, Manuela Guerreiro, Jayne E. Freeman, Judi A. Ellis · 2015 · Journal of Clinical and Experimental Neuropsychology
  25. Audiometric evaluation in patients with Alzheimer’s disease
    Alexandre Villeneuve, Caroline Hommet, Charles Aussedat, E. Lescanne, K. Reffet, D. Bakhos · 2016 · European Archives of Oto-Rhino-Laryngology
  26. Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects
    Miguel Ángel Araque Caballero, Matthias Brendel, Andreas Delker, Jinyi Ren, Axel Rominger, Peter Bartenstein, Martin Dichgans, Michael Walter Weiner, Michael Ewers · 2015 · Neurobiology of Aging
  27. Amyloidosis and neurodegeneration result in distinct structural connectivity patterns in mild cognitive impairment
    Thomas Jacquemont, Fabrizio De Vico Fallani, Anne Bertrand, Stéphane Epelbaum, Alexandre Routier, Bruno Dubois, Harald Juergen Hampel, Stanley Durrleman, Olivier Colliot A · 2017 · Neurobiology of Aging
  28. Prefrontal working memory activity predicts episodic memory performance: A neuroimaging study
    Rebecca J. Melrose, Evan Zahniser, Stacy Schantz Wilkins, Joseph Veliz, Arpi S. Hasratian, David L. Sultzer, Amy M. Jimenez · 2019 · Behavioural Brain Research
  29. How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years
    Stéphane Epelbaum, Claire Paquet, Jacques Hugon, Julien Dumurgier, David Wallon, Didier Hannequin, Thérèse Jonveaux, Annick Besozzi, Stéphane Pouponneau, Caroline Hommet et al. · 2019 · BMJ Open
  30. The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey
    Jenny Lam, Jakub P. Hlávka, Soeren Mattke · 2019 · The Journal of the American Board of Family Medicine
  31. Molecular Imaging of Alzheimer Disease Pathology
    Kejal Kantarci · 2014 · American Journal of Neuroradiology
  32. A liposome-based aptasensor integrated with competitive reaction enabling portable and electrochemical detection of Aβ oligomer
    Yuanyuan Hu, Xinguang Zhou, Liming Wang, Jinyu Gu, Yingchun Zuo, Li Zhao, Wenwen Lu, Yanyan Yu · 2023 · Biosensors and Bioelectronics
  33. Usefulness of CSF Biomarkers in Predicting the Progression of Amnesic and Nonamnesic Mild Cognitive Impairment to Alzheimer’s Disease
    Ricard López Ortega, Farida Dakterzada, Alfonso Martínez Arias, E. Blasco, Alba Naudí, Francisco F. Purroy, Gerard Piñol‐Ripoll · 2019 · Current Aging Science
  34. Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
    Panagiotis Alexopoulos, Lukas Werle, Jennifer Roesler, Nathalie Thierjung, Lena Sophie Gleixner, Igor Y. Yakushev, Nikolaos Laskaris, Stefan Wagenpfeil, Philippos Gourzis, Alexander Kurz et al. · 2016 · Alzheimer s Research & Therapy
  35. Restoring microglial and astroglial homeostasis using DNA immunization in a down Syndrome mouse model.
    Illouz, Tomer, Madar, Ravit, Biragyn, Arya, Okun, Eitan · 2019 · Brain, Behavior, and Immunity
  36. Future Directions in Imaging Neurodegeneration
    Joseph C. Masdeu · 2017 · Current Neurology and Neuroscience Reports
  37. Associations of Dietary Pattern and Sleep Duration with Cognitive Decline in Community-Dwelling Older Adults: A Seven-Year Follow-Up Cohort Study
    Xianwen Shang, Allison M. Hodge, Edward Hill, Zhuoting Zhu, Mingguang He · 2021 · Journal of Alzheimer s Disease
  38. Differentiating Between Healthy Control Participants and Those with Mild Cognitive Impairment Using Volumetric MRI Data
    Renée C. Groechel, Lauren Zajac, Asim Z. Mian, Anna Marisa Cervantes-Arslanian, Eric G. Steinberg, Michael Louis Alosco, Jesse B Mez, Robert A. Stern, Ronald Killany, Alzheimer’s Disease Neuroimaging Initiative · 2019 · Journal of the International Neuropsychological Society
  39. PET Neuroimaging in Dementia Conditions
    Daniela Perani, Silvia Paola Caminiti, Giulia Carli, Giacomo Tondo · 2020 · Springer eBooks
  40. The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease
    Lukas Busch, Simone Eggert, Kristina Endres, Bernd Bufe · 2022 · Cells
  41. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment
    David S. Knopman, Clifford R. Jack, Emily S. Lundt, Heather J. Wiste, Stephen D. Weigand, Prashanthi Vemuri, Val J. Lowe, Kejal Kantarci, Jeffrey L. Gunter, Matthew L. Senjem et al. · 2015 · JAMA Neurology
  42. Comparative Effects of Physical Exercise and Other Behavioral Interventions on Functional Status Outcomes in Mild Cognitive Impairment
    Anne L. Shandera‐Ochsner, Melanie J. Chandler, Dona E.C. Locke, Colleen T. Ball, Julia E. Crook, Vaishali S. Phatak, Glenn E. Smith · 2021 · Journal of the International Neuropsychological Society
  43. Addenbrooke’s Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment
    Lucy Beishon, Angus P Batterham, Terry J Quinn, Christopher P. Nelson, Ronney Bernardes Panerai, Thompson Gordon Robinson, Victoria Joanna Haunton · 2019 · Cochrane Database of Systematic Reviews
  44. Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer’s Disease
    Joshua P. White, Adrian J. Schembri, Carmen Prenn-Gologranc, Matej Ondrus, Stanislav Katina, Petr Novák, Yen Ying Lim, Chris J. Edgar, Paul T. Maruff · 2023 · Journal of Alzheimer s Disease
  45. The Relationship between Amyloid Deposition, Neurodegeneration, and Cognitive Decline in Dementia
    Rik R. Vandenberghe · 2014 · Current Neurology and Neuroscience Reports
  46. Defining SNAP by cross-sectional and longitudinal definitions of neurodegeneration
    Laura E.M. Wisse, Sandhitsu R. Das, Christos A. Davatzikos, Bradford Clark Dickerson, Sharon Xiangwen Xie, Paul A. Yushkevich, David A. Wolk · 2018 · NeuroImage Clinical
  47. Evaluation of the Efficacy and Feasibility of a Telerehabilitation Program Using Language and Cognitive Exercises in Multi-Domain Amnestic Mild Cognitive Impairment
    Αναστασία Νούσια, Evangelia Pappa, Vasileios Siokas, Ioannis Liampas, Zisis Tsouris, Lambros Messinis, Panayiotis Patrikelis, Christina Manouilidou, Efthimios Dardiotis, Grigorios Nasios · 2022 · Archives of Clinical Neuropsychology
  48. New criteria for Alzheimer’s disease: which, when and why?
    Jonathan M. Schott, Ronald Carl Petersen · 2015 · Brain
  49. Indole Compound NC009-1 Augments APOE and TRKA in Alzheimer’s Disease Cell and Mouse Models for Neuroprotection and Cognitive Improvement
    Yi-Chun Chen, Ya‐Jen Chiu, Chih‐Hsin Lin, Wen‐Chuin Hsu, Jia-Lu Wu, Chen-Hsiang Huang, Chia-Wei Lin, Ching‐Fa Yao, Hei-Jen Huang, Yen‐Shi Lo et al. · 2019 · Journal of Alzheimer s Disease
  50. Advances in PET imaging of protein aggregates associated with neurodegenerative disease
    Makoto Higuchi, Kenji Tagai, Keisuke Takahata, Hironobu Endo · 2025 · Nature Reviews Neurology
  51. Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease
    Panagiotis Alexopoulos, Lena Sophie Gleixner, Lukas Werle, Felix Buhl, Nathalie Thierjung, Evangelia Giourou, Simone Maria Kagerbauer, Philippos Gourzis, Hubert R Kübler, Timo Grimmer et al. · 2017 · European Archives of Psychiatry and Clinical Neuroscience
  52. Implications for microglial sex differences in tau-related neurodegenerative diseases
    Yasmine V. Doust, Anna Elizabeth King, Jenna M. Ziebell · 2021 · Neurobiology of Aging
  53. Aβ1-17 is a Major Amyloid-β Fragment Isoform in Cerebrospinal Fluid and Blood with Possible Diagnostic Value in Alzheimer's Disease
    Virginia Pérez‐Grijalba, Pedro Pesini, José Antonio Allué, Leticia Sarasa, María Montañés, Ana-María Lacosta, Diego Casabona, Itziar San José, Merçé Boada, Lluís Tárraga et al. · 2014 · Journal of Alzheimer s Disease
  54. Application of the IWG-2 Diagnostic Criteria for Alzheimer’s Disease to the ADNI
    Hui-Fu Wang, and Alzheimer’s Disease Neuroimaging Initiative, Lan Tan, Lei Cao, Xi‐Chen Zhu, Teng Jiang, Meng‐Shan Tan, Ying Liu, Chong Wang, Richard M. Tsai et al. · 2016 · Journal of Alzheimer s Disease
  55. Can the RAVLT predict deterioration from MCI to dementia? Data from long term follow up
    Liraz Dawidowicz, Elissa L. Ash, Amos D. Korczyn, Fani Andelman, Sigal Levy, Odelia Elkana · 2021 · Experimental Aging Research
  56. The role of neuroimaging in Alzheimer’s disease: implications for the diagnosis, monitoring disease progression, and treatment
    Julius Mulumba, Rui Duan, Bo Luo, Jiang Wu, Muhammad Sulaiman, Feng Wang, Yong Yang · 2025 · Exploration of neuroscience
  57. Edge Strand Dissociation and Conformational Changes in Transthyretin under Amyloidogenic Conditions
    Matthew Carter Childers, Valerie Daggett · 2020 · Biophysical Journal
  58. The New Criteria for Alzheimer’s Disease - Implications for Geriatricians*
    Pierre Molin, Kenneth J. Rockwood · 2016 · Canadian Geriatrics Journal
  59. Joint Assessment of Quantitative 18 F-Florbetapir and 18 F-FDG Regional Uptake Using Baseline Data from the ADNI
    Fayçal Ben Bouallègue, Denis Mariano‐Goulart, Pierre Payoux, Alzheimer’s Disease Neuroimaging Initiative · 2018 · Journal of Alzheimer s Disease
  60. The relationship of semantic intrusions to different etiological subtypes of MCI and cognitively healthy older adults
    Marcela Kitaigorodsky, Elizabeth Crocco, Rosie E. Curiel, Giselle Mirtes Amaral Leal, D. Diane Zheng, Melissa K. Eustache, Maria T. Greig‐Custo, William Barker, Ranjan Duara, David Loewenstein · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  61. Cerebrovascular disease in suspected non‐Alzheimer's pathophysiology and cognitive decline over time
    Francis N. Saridin, Kimberly Ann Chew, Anthonin Reilhac, Bibek Gyanwali, Steven Gayoles Villaraza, Tomotaka Tanaka, Philip Scheltens, Wiesje M. van der Flier, Christopher Chen, Saima Hilal · 2022 · European Journal of Neurology
  62. Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers
    Rosebud O. Roberts, David S. Knopman, Jeremy A. Syrjanen, Jeremiah A. Aakre, Maria E. Vassilaki, Walter K. Kremers, Michelle M. Mielke, Mary M. Machulda, Jonathan Graff‐Radford, Yonas E. Geda et al. · 2017 · Neurology
  63. Neuroimaging of Diseases Causing Dementia
    Joseph C. Masdeu · 2019 · Neurologic Clinics
  64. Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?
    Joshua D. Grill, Michelle M. Nuño, Daniel L. Gillen · 2019 · Alzheimer Disease & Associated Disorders
  65. Imaging and Cerebrospinal Fluid Biomarkers in the Search for Alzheimer's Disease Mechanisms
    Ricardo S. Osorio, Elizabeth Pirraglia, Tyler Gumb, Janna Mantua, Indu A. Ayappa, S. Williams, Lisa Mosconi, Lidia Glodzik, Mony J. de Leon · 2013 · Neurodegenerative Diseases
  66. Serum levels of soluble TNF-α receptors but not BDNF are associated with apathy symptoms in mild Alzheimer's disease and amnestic mild cognitive impairment
    Henrique Cerqueira Guimarães, Paulo Caramelli, Patrícia Paes Araujo Fialho, Elisa de Paula França, Marcelo Pellizzaro Dias Afonso, Antônio Lúcio Teixeira · 2013 · Dementia & Neuropsychologia
  67. APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer’s Disease
    Timothy J. Hohman, Logan C. Dumitrescu, Amy Oksol, Madison A. Wagener, Katherine A. Gifford, Angela Lee Jefferson, Alzheimer’s Disease Neuroimaging Initiative · 2017 · PLoS ONE
  68. Revisiting Aspect in Mild Cognitive Impairment and Alzheimer's Disease: Evidence From Greek
    Christina Manouilidou, Γεωργία Ρουμπέα, Αναστασία Νούσια, Stavroula Stavrakaki, Grigorios Nasios · 2020 · Frontiers in Communication
  69. Multimodal Fusion of Smart Home and Text-based Behavior Markers for Clinical Assessment Prediction
    Gina Sprint, Diane J. Cook, Maureen Schmitter‐Edgecombe, Lawrence B. Holder · 2022 · ACM Transactions on Computing for Healthcare
  70. Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer’s Disease Neuroimaging Initiative
    Barbara E. Spencer, Robin G. Jennings, James B. Brewer, Alzheimer’s Disease Neuroimaging Initiative · 2019 · Journal of Alzheimer s Disease
  71. SERF , a family of tiny highly conserved, highly charged proteins with enigmatic functions
    Bikash Ranjan Sahoo, James C.A. Bardwell · 2022 · FEBS Journal
  72. Is there a specific memory signature associated with Aβ-PET positivity in patients with amnestic mild cognitive impairment?
    Clémence Tomadesso, Julie Gonneaud, Stéphanie Egret, Audrey Perrotin, Alice Pèlerin, Robin de Florès, Vincent de La Sayette, Béatrice Desgranges, Gaël Chételat, Renaud La Joie · 2019 · Neurobiology of Aging
  73. Fluorescence-based techniques for the detection of the oligomeric status of proteins: implication in amyloidogenic diseases
    Lipika Mirdha, Hirak Chakraborty · 2021 · European Biophysics Journal
  74. Prevalence Estimation of Dementia/Alzheimer's Disease Using Health and Retirement Study Database in the United States
    Amir Abbas Tahami Monfared, Noemi Hummel, Aastha N. Chandak, Artak Khachatryan, Rui Zhang, Qiang Zhang · 2024 · The Journal of Prevention of Alzheimer s Disease
  75. Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature
    Tina Milos, Barbara Vuić, Nikola Balic, Vladimir Farkaš, Gordana Nedić Erjavec, Dubravka Švob Štrac, Matea Nikolac Perković, Nela Pivac · 2024 · Expert Review of Neurotherapeutics
  76. Cognitive training for Alzheimer's disease and other forms of dementia: Insights from a systematic review and Bayesian meta-analysis
    Francesco Giaquinto, Marika Iaia, Ezia Rizzi, Luigi Macchitella, Daniele Luigi Romano, Giorgia Tosi, Paola Angelelli · 2025 · Journal of Alzheimer s Disease
  77. Memory for public events in amnestic mild cognitive impairment: The role of hippocampus and ventro‐medial prefrontal cortex
    Laura Serra, Maria Stefania De Simone, Lucia Fadda, Roberta Perri, Carlo Caltagirone, Marco Bozzali, Giovanni Augusto Carlesimo · 2021 · Journal of Neuropsychology
  78. The relationship between vascular endothelial growth factor (VEGF) and amnestic mild cognitive impairment among older adults living with HIV
    Vanessa B. Serrano, Jessica L. Montoya, Laura M. Campbell, Erin E. Sundermann, Jennifer E. Iudicello, Scott Lee Letendre, Robert K. Heaton, David J. Moore · 2021 · Journal of NeuroVirology
  79. Connectome-based biophysics models of Alzheimer’s disease diagnosis and prognosis
    Justin Torok, Chaitali Anand, Parul Verma, Ashish Raj · 2022 · Translational research
  80. The Proactive Self in Space: How Egocentric and Allocentric Spatial Impairments Contribute to Anosognosia in Alzheimer’s Disease
    Silvia Serino, Giuseppe Riva · 2016 · Journal of Alzheimer s Disease
  81. Diagnostic and prognostic value of amyloid PET textural and shape features: comparison with classical semi-quantitative rating in 760 patients from the ADNI-2 database
    F. Ben Bouallègue, F. Vauchot, D. Mariano-Goulart, P. Payoux · 2018 · Brain Imaging and Behavior
  82. Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer’s Disease Pathology
    Jun Ku Chung, Alzheimer’s Disease Neuroimaging Initiative, Eric Plitman, Shinichiro Nakajima, Fernando Caravaggio, Yusuke Iwata, Philip Gerretsen, Julia Kim, Hiroyoshi Takeuchi, Shunichiro Shinagawa et al. · 2017 · Journal of Alzheimer s Disease
  83. Positron Emission Tomography and Single-Photon Emission Computed Tomography in Neurology
    Robert S. Miletich · 2016 · CONTINUUM Lifelong Learning in Neurology
  84. Sustaining prospective memory functioning in amnestic mild cognitive impairment: A lifespan approach to the critical role of encoding.
    Antonina Pereira, Mareike Altgassen, Lesley Atchison, Alexandre de Mendonça, Judi A. Ellis · 2018 · Neuropsychology
  85. Mild cognitive impairment—amyloid and beyond
    Philip Scheltens · 2013 · Nature Reviews Neurology
  86. O espectro clínico e laboratorial da doença de Alzheimer
    Marcos Aurélio Moreira, Shirlene Vianna Moreira · 2020 · Revista Psicologia em Pesquisa
  87. Diagnostic Utility of Hippocampal Volumetric Data in a Memory Disorder Clinic Setting
    Robert Ruchinskas, Trung Nguyen, Kyle Womack, Alka Khera, Fang F. Yu, Brendan J. Kelley · 2022 · Cognitive and Behavioral Neurology
  88. Are we ready to use anti-amyloid therapy in Alzheimer's disease?
    Sônia Maria Dozzi Brucki, Karolina Gouveia César‐Freitas, Raphael Ribeiro Spera, Conrado Regis Borges, Jerusa Smid · 2022 · Arquivos de Neuro-Psiquiatria
  89. Characteristics of macroscopic sleep structure in patients with mild cognitive impairment: a systematic review
    Yahui Liang, Weihua Liu, Meizi Wang · 2023 · Frontiers in Psychiatry
  90. Les nouveaux critères de la Maladie d’Alzheimer – Perspective gériatrique*
    Pierre Molin, Kenneth J. Rockwood · 2016 · Canadian Geriatrics Journal
  91. Semantic-based memory-encoding strategy and cognitive stimulation in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised cluster controlled trial
    Hannah Mraz, Choy-Ying Tong, Karen P. Y. Liu · 2023 · PLoS ONE
  92. Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with MCI
    Nicola Salvadori, Edoardo Guido Torrigiani, Federico Paolini Paoletti, Elena Chipi, Chiara Montanucci, Claudio Verderosa, Elisa Siena, Daniela Fruttini, Lucilla Parnetti · 2024 · Scientific Reports
  93. ERP C250 shows the elderly (cognitively normal, Alzheimer’s disease) store more stimuli in short-term memory than Young Adults do
    Robert M. Chapman, Margaret N. Gardner, Mark E. Mapstone, Rafael Klorman, Anton P. Porsteinsson, Haley M. Dupree, Inga Margret Antonsdottir, Lily Kamalyan · 2016 · Clinical Neurophysiology
  94. Validation of prognostic biomarker scores for predicting progression of dementia in patients with amnestic mild cognitive impairment
    Jamie Moreland, Timo Urhemaa, Mark van Gils, Jyrki M. P. Lötjönen, Jan Wolber, Christopher J. Buckley · 2018 · Nuclear Medicine Communications
  95. Alzheimers's disease: Epidemiological characteristics and its prevention
    Jovan Grujičić, Aleksandra Nikolić · 2021 · Zdravstvena zastita
  96. Do preclinical Alzheimer's disease criteria work?
    Ronald Carl Petersen · 2013 · The Lancet Neurology
  97. Adulthood cognitive trajectories over 26 years and brain health at 70 years of age: findings from the 1946 British Birth Cohort
    Sarah‐Naomi James, Jennifer M. Nicholas, Kirsty Lu, Ashvini Keshavan, Chris Lane, Thomas D. Parker, Sarah M. Buchanan, Sarah E Keuss, Heidi Murray‐Smith, Andrew Wong et al. · 2022 · Neurobiology of Aging
  98. Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries
    Haixin Zhang, Amir Abbas Tahami Monfared, Quanwu Zhang, Lawrence S. Honig · 2024 · Neurology and Therapy
  99. Disease trajectories in older adults with non-AD pathologic change and comparison with Alzheimer’s disease pathophysiology: A longitudinal study
    Jieqiong Li, Jinghui Song, John Suckling, Yan‐Jiang Wang, Chuantao Zuo, Can Martin Zhang, Jing Gao, Yuqiang Song, Anmu Xie, Lan Tan et al. · 2023 · Neurobiology of Aging
  100. Genetic and degenerative disorders primarily causing dementia
    Joseph C. Masdeu, Belén Pascual · 2016 · Handbook of clinical neurology